Abstract
Squamous cell carcinoma accounts for more than 95% of malignant penile neoplasms. The pattern of dissemination is predominantly lymphogenic to the inguinal nodes. Treatment of patients with penile carcinoma and proven inguinal metastases is straightforward, and consists of treatment of the primary lesion and regional lymph node dissection. For individuals with impalpable nodes, however, treatment has been a subject of debate for many years. Routine elective inguinal lymph node dissection leads to overtreatment in the majority of patients because of the low incidence of occult lymph node metastases. On the other hand, a wait-and-see policy harbors the risk of patients presenting with metastasis at a stage when cure is no longer possible (1). Unfortunately, primary tumor characteristics are rather unreliable in predicting occult metastases (2),(3). In addition, staging with computerized tomography and magnetic resonance imaging has so far not been shown to improve the accuracy of detecting occult metastases (4). Staging with ultrasound along with fine-needle aspiration biopsy is more accurate, but still has a relatively low sensitivity (5).
Portions of this chapter are reprinted from Kroon BK, Horenblas S, Nieweg OE. Contemporary management of penile squamous cell carcinoma. J Surg Oncol 2005;89:43–50. Reprinted with permission of Wiley-Liss, Inc. a subsidiary of John Wiley & Sons, Inc.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Horenblas S, van Tinteren H, Delemarre JF, et al. Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J Urol. 1993;149:492–497.
Lopes A, Hidalgo GS, Kowalski LP, et al. Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol. 1996;156:1637–1642.
Slaton JW, Morgenstern N, Levy DA, et al. Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. J Urol. 2001;165:1138–1142.
Horenblas S, van Tinteren H, Delemarre JF, et al. Squamous cell carcinoma of the penis: accuracy of tumor, nodes and metastasis classification system, and role of lymphangiography, computerized tomography scan and fine needle aspiration cytology. J Urol. 1991;146:1279–1283.
Kroon BK, Horenblas S, Deurloo EE, et al. Ultrasonography-guided fine-needle aspiration cytology before sentinel node biopsy in patients with penile carcinoma. BJU Int. 2005;95:517–521.
Crawford ED, Daneshgari F. Management of regional lymphatic drainage in carcinoma of the penis. Urol Clin North Am. 1992;19:305–317.
Baronofsky ID. Technique for inguinal node dissection. Surgery. 1948;24:555–567.
Young HH. A radical operation for the cure of cancer of the penis. J Urol. 1931;26:285.
Daseler EH, Anson BJ, Reimann AF. Radical excision of the inguinal and iliac lymph glands: a study based upon 450 anatomical dissections and upon supportive clinical observations. Surg Gynecol Obstet. 1948;87:679–694.
Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39:456–466.
Catalona WJ. Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous veins: technique and preliminary results. J Urol. 1988;140:306–310.
Bevan-Thomas R, Slaton JW, Pettaway CA. Contemporary morbidity from lymphadenectomy for penile squamous cell carcinoma: the M.D. Anderson Cancer Center Experience. J Urol. 2002;167:1638–1642.
Kroon BK, Lont AP, Valdes Olmos RA, et al. Morbidity of dynamic sentinel node biopsy in penile carcinoma. J Urol. 2005;173:813–815.
Lopes A, Rossi BM, Fonseca FP, et al. Unreliability of modified inguinal lymphadenectomy for clinical staging of penile carcinoma. Cancer. 1996;77:2099–2102.
d’Ancona CA, de Lucena RG, Querne FA, et al. Long-term follow-up of penile carcinoma treated with penectomy and bilateral modified inguinal lymphadenectomy. J Urol. 2004;172:498–501.
Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–399.
Horenblas S, Jansen L, Meinhardt W, et al. Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure. J Urol. 2000;163:100–104.
Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin. 1999;49:8–31.
Frisch M, Friis S, Kjaer SK, et al. Falling incidence of penis cancer in an uncircumcised population (Denmark 1943–90). BMJ. 1995;311:1471.
Persky L. Epidemiology of cancer of the penis. Recent results. Cancer Res. 1977;60:97–109.
Ornellas AA, Seixas AL, Marota A, et al. Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J Urol. 1994;151:1244–1249.
Dillner J, Meijer CJ, von Krogh G, et al. Epidemiology of human papillomavirus infection. Scand J Urol Nephrol Suppl. 2000;205:194–200.
Harish K, Ravi R. The role of tobacco in penile carcinoma. Br J Urol. 1995;75:375–377.
Ferreux E, Lont AP, Horenblas S, et al. Evidence for at least 3 alternative mechanisms targeting the p16INK4A/cyclin D/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J Pathol. 2003;201:109–118.
Griffiths M. Detection of human papilloma virus DNA in semen from patients with intrameatal penile warts. Genitourin Med. 1990;66:229–230.
Burgers JK, Badalament RA, Drago JR. Penile cancer. Clinical presentation, diagnosis, and staging. Urol Clin North Am. 1992;19:247–256.
Misra S, Chaturvedi A, Misra NC. Penile carcinoma: a challenge for the developing world. Lancet Oncol. 2004;5:240–247.
Kroon BK, Horenblas S, Nieweg OE. Contemporary management of penile squamous cell carcinoma. J Surg Oncol. 2005;89:43–50.
Culkin DJ, Beer TM. Advanced penile carcinoma. J Urol. 2003;170:359–365.
Horenblas S, van Tinteren H, Delemarre JF, et al. Squamous cell carcinoma of the penis. II. Treatment of the primary tumor. J Urol. 1992;147:1533–1538.
Abi-Aad AS, deKernion JB. Controversies in ilioinguinal lymphadenectomy for cancer of the penis. Urol Clin N Am. 1992;19:319–324.
Senthil Kumar MP, Ananthakrishnan N, Prema V. Predicting regional lymph node metastasis in carcinoma of the penis: a comparison between fine-needle aspiration cytology, sentinel lymph node biopsy and medial inguinal lymph node biopsy. Br J Urol. 1998;81:453–457.
Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: the role and technique of lymph node dissection. BJU Int. 2001;88:473–483.
Broders AC. Carcinoma: grading and practical applications. Arch Pathol Lab Med. 1926;2:376–381.
Villavicencio H, Rubio-Briones J, Regalado R, et al. Grade, local stage and growth pattern as prognostic factors in carcinoma of the penis. Eur Urol. 1997;32:442–447.
Solsona E, Iborra I, Ricos JV, et al. Corpus cavernosum invasion and tumor grade in the prediction of lymph node condition in penile carcinoma. Eur Urol. 1992;22:115–118.
Demkow T. The treatment of penile carcinoma: experience in 64 cases. Int Urol Nephrol. 1999;31:525–531.
McDougal WS. Carcinoma of the penis: improved survival by early regional lymphadenectomy based on the histological grade and depth of invasion of the primary lesion. J Urol. 1995;154:1364–1366.
Solsona E, Iborra I, Rubio J, et al. Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. J Urol. 2001;165:1506–1509.
Theodorescu D, Russo P, Zhang ZF, et al. Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes. J Urol. 1996;155:1626–1631.
Koch MO, McDougal WS. Penile carcinoma: the case for primary lymphadenectomy. Cancer Treat Res, 1989;46:55.
Cabanas RM. Anatomy and biopsy of sentinel lymph nodes. Urol Clin North Am. 1992;19:267–276.
Dewire D, Lepor H. Anatomic considerations of the penis and its lymphatic drainage. Urol Clin North Am. 1992;19:211–219.
Kroon BK, Valdes Olmos R, Nieweg OE, et al. Nonvisualization of sentinel lymph nodes in penile carcinoma. Eur J Nucl Med Mol Imaging. 2005;32:1096–1099.
Valdes Olmos RA, Tanis PJ, Hoefnagel CA, et al. Penile lymphoscintigraphy for sentinel node identification. Eur J Nucl Med. 2001;28:581–585.
Lopes A, Bezerra AL, Serrano SV, Hidalgo GS. Iliac nodal metastases from carcinoma of the penis treated surgically. BJU Int. 2000;86:690–693.
Srinivas V, Morse MJ, Herr HW, et al. Penile cancer: relation of extent of nodal metastasis to survival. J Urol. 1987;137:880–882.
McDougal WS, Kirchner FK Jr, Edwards RH, Killion LT. Treatment of carcinoma of the penis: the case for primary lymphadenectomy. J Urol. 1986;136:38–41.
Johnson DE, Lo RK. Management of regional lymph nodes in penile carcinoma. Five-year results following therapeutic groin dissections. Urology. 1984;24:308–311.
Ravi R. Morbidity following groin dissection for penile carcinoma. Br J Urol. 1993;72:941–945.
Kroon BK, Horenblas S, Meinhardt W, et al. Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10 years experience. Eur Urol. 2005;47:601–606.
Bouchot O, Rigaud J, Maillet F, et al. Morbidity of inguinal lymphadenectomy for invasive penile carcinoma. Eur Urol. 2004;45:761–765.
Colberg JW, Andriole GL, Catalona WJ. Long-term follow-up of men undergoing modified inguinal lymphadenectomy for carcinoma of the penis. Br J Urol. 1997;79:54–57.
Parra RO. Accurate staging of carcinoma of the penis in men with nonpalpable inguinal lymph nodes by modified inguinal lymphadenectomy. J Urol. 1996;155:560–563.
Wawroschek F, Vogt H, Bachter D, et al. First experience with gamma probe guided sentinel lymph node surgery in penile cancer. Urol Res. 2000;28:246–249.
Han KR, Brogle BN, Goydos J, et al. Lymphatic mapping and intraoperative lymphoscintigraphy for identifying the sentinel node in penile tumors. Urology. 2000;55:582–585.
Akduman B, Fleshner NE, Ehrlich L, et al. Early experience in intermediate-risk penile cancer with sentinel node identification using the gamma probe. Urology. 2001;58:65–68.
Steinbecker KM, Muruve NA. Lymphoscintigraphy for penile cancer. J Urol. 2000;163:1251–1252.
Izawa J, Kedar D, Wong F, et al. Sentinel lymph node biopsy in penile cancer: evolution and insights. Can J Urol. 2005;12(suppl 1):24–29.
Perdona S, Gallo L, Claudio L, et al. Role of crural inguinal lymphadenectomy and dynamic sentinel lymph node biopsy in lymph node staging in squamous-cell carcinoma of the penis. Our experience. Tumori. 2003;89:276–279.
Kroon BK, Horenblas S, Estourgie SH, et al. How to avoid false-negative dynamic sentinel node procedures in penile carcinoma. J Urol. 2004;171:2191–2194.
Tanis PJ, Lont AP, Meinhardt W, et al. Dynamic sentinel node biopsy for penile cancer: reliability of a staging technique. J Urol. 2002;168:76–80.
Hwang RF, Krishnamurthy S, Hunt KK, et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol. 2003;10:248–254.
Lee JH, Essner R, Torisu-Itakura H, et al. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma. J Clin Oncol. 2004;22:3677–3684.
Starz H, Balda BR, Kramer KU, et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer. 2001;91:2110–2121.
Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003;348:2491–2499. Erratum in N Engl J Med. 2003;349:1010.
Rockall AG, Sohaib SA, Harisinghani MG, et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol. 2005;23:2813–2821. Erratum in J Clin Oncol. 2005;23:4808.
Wunderbaldinger P, Josephson L, Bremer C, et al. Detection of lymph node metastases by contrast-enhanced MRI in an experimental model. Magn Reson Med. 2002;47:292–297.
McDougal WS. Preemptive lymphadenectomy markedly improves survival in patients with cancer of the penis who harbor occult metastases. J Urol. 2005;173:681.
van de Vijver MJ, He YD, van’t Veer LJ, et al. A geneexpression signature as a predictor of survival in breast cancer. N Engl J Med. 2002;347:1999–2009.
Roepman P, Wessels LF, Kettelarij N, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet. 2005;37:182–186.
Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penis. Part 1: diagnosis of the lymph node metastasis. BJU Int. 2001;88:467–472.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Horenblas, S., Kroon, B.K., Valdés Olmos, R.A., Nieweg, O.E. (2008). Dynamic Sentinel Lymph Node Biopsy in Penile Carcinoma. In: Mariani, G., Giuliano, A.E., Strauss, H.W. (eds) Radioguided Surgery. Springer, New York, NY. https://doi.org/10.1007/978-0-387-38327-9_11
Download citation
DOI: https://doi.org/10.1007/978-0-387-38327-9_11
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-33684-8
Online ISBN: 978-0-387-38327-9
eBook Packages: MedicineMedicine (R0)